Logo image of CY4.MI

CY4GATE SPA (CY4.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:CY4 - IT0005412504 - Common Stock

8.12 EUR
0 (0%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CY4. CY4 was compared to 113 industry peers in the Software industry. CY4 may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CY4 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CY4 has reported negative net income.
CY4 had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CY4 reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CY4 reported negative operating cash flow in multiple years.
CY4.MI Yearly Net Income VS EBIT VS OCF VS FCFCY4.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.06%, CY4 is doing worse than 78.76% of the companies in the same industry.
Looking at the Return On Equity, with a value of -18.20%, CY4 is doing worse than 74.34% of the companies in the same industry.
Industry RankSector Rank
ROA -9.06%
ROE -18.2%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CY4.MI Yearly ROA, ROE, ROICCY4.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

Looking at the Gross Margin, with a value of 43.51%, CY4 is doing worse than 74.34% of the companies in the same industry.
In the last couple of years the Gross Margin of CY4 has remained more or less at the same level.
CY4 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y-0.54%
CY4.MI Yearly Profit, Operating, Gross MarginsCY4.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

3

2. Health

2.1 Basic Checks

CY4 does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for CY4. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CY4.MI Yearly Shares OutstandingCY4.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
CY4.MI Yearly Total Debt VS Total AssetsCY4.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

CY4 has an Altman-Z score of 1.53. This is a bad value and indicates that CY4 is not financially healthy and even has some risk of bankruptcy.
CY4's Altman-Z score of 1.53 is on the low side compared to the rest of the industry. CY4 is outperformed by 65.49% of its industry peers.
The Debt to FCF ratio of CY4 is 3.47, which is a good value as it means it would take CY4, 3.47 years of fcf income to pay off all of its debts.
CY4 has a Debt to FCF ratio (3.47) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.23 indicates that CY4 is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.23, CY4 is in line with its industry, outperforming 56.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 3.47
Altman-Z 1.53
ROIC/WACCN/A
WACC8.52%
CY4.MI Yearly LT Debt VS Equity VS FCFCY4.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 1.32 indicates that CY4 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.32, CY4 perfoms like the industry average, outperforming 45.13% of the companies in the same industry.
A Quick Ratio of 1.29 indicates that CY4 should not have too much problems paying its short term obligations.
CY4 has a Quick ratio of 1.29. This is comparable to the rest of the industry: CY4 outperforms 47.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.29
CY4.MI Yearly Current Assets VS Current LiabilitesCY4.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

6

3. Growth

3.1 Past

CY4 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.22%, which is quite impressive.
Looking at the last year, CY4 shows a very strong growth in Revenue. The Revenue has grown by 28.46%.
The Revenue has been growing by 59.24% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)41.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.13%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y61.94%
Revenue growth 5Y59.24%
Sales Q2Q%32.24%

3.2 Future

Based on estimates for the next years, CY4 will show a very strong growth in Earnings Per Share. The EPS will grow by 33.72% on average per year.
CY4 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.12% yearly.
EPS Next Y17.64%
EPS Next 2Y38.05%
EPS Next 3Y33.72%
EPS Next 5YN/A
Revenue Next Year13.24%
Revenue Next 2Y10.38%
Revenue Next 3Y9.12%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CY4.MI Yearly Revenue VS EstimatesCY4.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CY4.MI Yearly EPS VS EstimatesCY4.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CY4. In the last year negative earnings were reported.
Also next year CY4 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CY4.MI Price Earnings VS Forward Price EarningsCY4.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CY4 indicates a slightly more expensive valuation: CY4 is more expensive than 61.06% of the companies listed in the same industry.
82.30% of the companies in the same industry are more expensive than CY4, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.88
EV/EBITDA 53.31
CY4.MI Per share dataCY4.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as CY4's earnings are expected to grow with 33.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.05%
EPS Next 3Y33.72%

0

5. Dividend

5.1 Amount

No dividends for CY4!.
Industry RankSector Rank
Dividend Yield N/A

CY4GATE SPA

BIT:CY4 (12/12/2025, 7:00:00 PM)

8.12

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners12.74%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap191.39M
Revenue(TTM)113.27M
Net Income(TTM)-16.38M
Analysts86.67
Price Target6.73 (-17.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP2.35%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.09%
PT rev (3m)13.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.3%
EPS NY rev (3m)-63.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.69
P/FCF 16.88
P/OCF 14.18
P/B 2.13
P/tB 14.8
EV/EBITDA 53.31
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.48
FCFY5.92%
OCF(TTM)0.57
OCFY7.05%
SpS4.81
BVpS3.82
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.06%
ROE -18.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.51%
FCFM 10.01%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y-0.54%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 3.47
Debt/EBITDA 5.15
Cap/Depr 9.94%
Cap/Sales 1.91%
Interest Coverage N/A
Cash Conversion 330.53%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.29
Altman-Z 1.53
F-Score5
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)19.8%
Cap/Depr(5y)17.04%
Cap/Sales(3y)4.99%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.13%
EPS Next Y17.64%
EPS Next 2Y38.05%
EPS Next 3Y33.72%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y61.94%
Revenue growth 5Y59.24%
Sales Q2Q%32.24%
Revenue Next Year13.24%
Revenue Next 2Y10.38%
Revenue Next 3Y9.12%
Revenue Next 5YN/A
EBIT growth 1Y16.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2716.67%
EBIT Next 3Y245.52%
EBIT Next 5YN/A
FCF growth 1Y57.74%
FCF growth 3YN/A
FCF growth 5Y87.64%
OCF growth 1Y25.87%
OCF growth 3YN/A
OCF growth 5Y43.36%

CY4GATE SPA / CY4.MI FAQ

Can you provide the ChartMill fundamental rating for CY4GATE SPA?

ChartMill assigns a fundamental rating of 3 / 10 to CY4.MI.


What is the valuation status of CY4GATE SPA (CY4.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to CY4GATE SPA (CY4.MI). This can be considered as Overvalued.


Can you provide the profitability details for CY4GATE SPA?

CY4GATE SPA (CY4.MI) has a profitability rating of 1 / 10.


What is the financial health of CY4GATE SPA (CY4.MI) stock?

The financial health rating of CY4GATE SPA (CY4.MI) is 3 / 10.